Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Japan”
- Antifibrotic Therapy Decision-Making in Pulmonary FibrosisNot Yet Recruiting
Sponsor: Bristol-Myers Squibb
Pulmonary Fibrosis · Idiopathic Pulmonary Fibrosis · Progressive Pulmonary Fibrosis
Japan
Sponsor: Boehringer Ingelheim
Small Cell Lung Carcinoma · Neuroendocrine Neoplasms · Extra-pulmonary Neuroendocrine Carcinoma
United States, Belgium, Bulgaria, China, France +7 more
Sponsor: Bristol-Myers Squibb
Colitis, Ulcerative
United States, Australia, Belgium, Canada, France +8 more
Sponsor: AstraZeneca
Systemic Lupus Erythematosus · Idiopathic Inflammatory Myopathies · Rheumatoid Arthritis
United States, Canada, China, France, Germany +5 more
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Myelodysplastic Syndrome · Acute Myeloid Leukemia
United States, Japan, Netherlands
Sponsor: Chinese PLA General Hospital
Delirium · Anxiety
China
- Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2Active Not Recruiting
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Urothelial Carcinoma
United States, Argentina, Australia, Belgium, Brazil +19 more
Sponsor: Gang Hou
Bronchoscopy · Learning Curves and Outcomes of Simulation-based Training · Learning Curve
China
Sponsor: AstraZeneca
High-risk Muscle Invasive Urothelial Carcinoma
United States, Australia, Brazil, Canada, China +11 more
- A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid TumorsActive Not Recruiting
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Breast Neoplasms · Gastroesophageal Junction Adenocarcinoma · HER2 Low Breast Neoplasms · HER2 Positive Breast Neoplasms
United States, Australia, Canada, Germany, Italy +5 more
Sponsor: Janssen Research & Development, LLC
Multiple Myeloma
United States, Argentina, Belgium, Brazil, Canada +16 more
Sponsor: Novartis Pharmaceuticals
Elevated Blood Pressure · Hypertension
Japan
Sponsor: Eli Lilly and Company
Obesity · Overweight
United States, Israel, Italy, Japan, Poland +1 more
Sponsor: Merck Sharp & Dohme LLC
Bladder Cancer
United States, Australia, Belgium, Canada, Denmark +17 more
Sponsor: Pfizer
Advanced/Metastatic Non-Small Cell Lung Cancer · Carcinoma, Non-Small Cell Lung · Non-Small Cell Lung Cancer
United States, China, France, Germany, Italy +4 more
- A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast CancerActive Not Recruiting
Sponsor: Eli Lilly and Company
Breast Neoplasms · Neoplasm Metastasis
United States, Argentina, Australia, Austria, Belgium +17 more
- Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or IntoleranceActive Not Recruiting
Sponsor: PharmaEssentia
Essential Thrombocythemia
United States, Canada, China, Hong Kong, Japan +3 more
- Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)Active Not Recruiting
Sponsor: Merck Sharp & Dohme LLC
Breast Neoplasms
United States, Argentina, Australia, Austria, Brazil +26 more
- Sacituzumab Tirumotecan (MK-2870) in Patients With Advanced Small Bowel Adenocarcinoma Refractory or Intolerant to Platinum-Based Combination TherapyNot Yet Recruiting
Sponsor: National Cancer Center, Japan
Advanced Small Bowel Adenocarcinoma
Japan
- A Phase 3 Study of Efficacy and Safety of AK3280 in Patients With Idiopathic Pulmonary FibrosisNot Yet Recruiting
Sponsor: Shanghai Ark Biopharmaceutical Co., Ltd.
Idiopathic Pulmonary Fibrosis (IPF)
China
Sponsor: Regeneron Pharmaceuticals
Amyotrophic Lateral Sclerosis (ALS) · Mutation in the Superoxide Dismutase-1 (SOD1) Gene
Australia, Belgium, Canada, Germany, Japan +4 more
Sponsor: Pfizer
Non-Small Cell Lung Cancer · Carcinoma, Non-Small-Cell Lung · Carcinoma, Non-Small-Cell Lung (NSCLC)
United States, Argentina, Australia, Austria, Belgium +26 more
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Colorectal Neoplasms · Carcinoma, Non-Small-Cell Lung · Stomach Neoplasms · Pancreatic Ductal Adenocarcinoma
United States, Canada, China, France, Israel +5 more
Sponsor: Merck Sharp & Dohme LLC
Esophageal Squamous Cell Carcinoma (ESCC) · Gastroesophageal Junction Carcinoma (GEJC) · Esophageal Adenocarcinoma (EAC)
United States, Argentina, Belgium, Brazil, Canada +22 more
Sponsor: Boehringer Ingelheim
Lung Diseases, Interstitial
Japan